ABCG2 and breast cancer: To test the hypothesis that ABCG2 polymorphisms is an independent prognostic factor in this cohort, we further evaluated the correlation of G34A, C421A polymorphisms, and the survival time of the BC patients with postoperative chemotherapies obtained from the Log-rank test and multivariate Cox regression analysis.